These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6105117)

  • 1. Ranitidine--a new H2-receptor antagonist.
    Woodings EP; Dixon GT; Harrison C; Carey P; Richards DA
    Gut; 1980 Mar; 21(3):187-91. PubMed ID: 6105117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in Heidenhain pouch dogs (author's transl)].
    Ohtsuki H; Okabe S
    Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):539-47. PubMed ID: 6120885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and gastric secretory studies of ranitidine in man.
    Louis WJ; Mihaly GW; Hanson RG; Anderson A; McNeil JJ; Yeomans ND; Smallwood RA
    Scand J Gastroenterol Suppl; 1981 Jun; 69():11-7. PubMed ID: 6119773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist.
    Peden NR; Saunders JH; Wormsley KG
    Lancet; 1979 Mar; 1(8118):690-2. PubMed ID: 85934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.
    Domschke W; Lux G; Domschke S
    Gastroenterology; 1980 Dec; 79(6):1267-71. PubMed ID: 6108279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide.
    Daly MJ; Humphray JM; Stables R
    Gut; 1980 May; 21(5):408-12. PubMed ID: 6107261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.
    Kett K; Aadland E; Berstad A
    Scand J Gastroenterol; 1980; 15(2):249-51. PubMed ID: 6104355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in rats: comparison with cimetidine (author's transl)].
    Okabe S; Kawakami M
    Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):57-62. PubMed ID: 6119281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships.
    Mignon M; Chau NP; Nguyen-Phuoc BK; Sauvage M; Leguy F; Bonfils S
    Br J Clin Pharmacol; 1982 Aug; 14(2):187-93. PubMed ID: 6125203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the histamine-stimulated gastric secretion in healthy subjects by the H2-receptor antagonist ranitidine.
    Bohman T; Myren J; Larsen S
    Scand J Gastroenterol; 1980; 15(2):183-9. PubMed ID: 6104354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
    Weingart J; Kunert H; Ottenjann R
    Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of intravenous ranitidine and its effect on gastric acid secretion stimulated by pentagastrin in the cirrhotic].
    Bretagne JF; Reymann JM; Tassou JJ; Allain H; Gosselin A; Gastard J
    Gastroenterol Clin Biol; 1983 Apr; 7(4):355-61. PubMed ID: 6135641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Müller P; Kather H; Simon B
    Res Exp Med (Berl); 1981; 178(2):151-4. PubMed ID: 6262889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the H2- receptor antagonist ranitidine in man.
    McNeil JJ; Mihaly GW; Anderson A; Marshall AW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1981 Sep; 12(3):411-5. PubMed ID: 6117305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.
    van Hecken AM; Tjandramaga TB; Mullie A; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1982 Aug; 14(2):195-200. PubMed ID: 6125204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine inhibits gastric acid and pepsin secretion following sham feeding.
    Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
    Hepatogastroenterology; 1980 Oct; 27(5):377-80. PubMed ID: 6110626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric inhibitory action of H2-antagonists ranitidine and cimetidine.
    Domschke W; Lux G; Domschke S
    Lancet; 1979 Feb; 1(8111):320. PubMed ID: 84968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.